GB-115: A New Era in Anxiety and Cognitive Enhancement

While the medical world takes decades to adopt new research, the evidence for a safer, more effective anxiolytic is already here. Dive deep into GB-115. Last Updated: June 19, 2025 Why Isn’t This a Global Standard? “The medical community faces a significant lag… with pharmacological advancements taking an average of 21 years to integrate into […]

Read More →

ACD856: A Paradigm Shift in Antidepressant Therapy

The Current Standard: SSRIs and Their Inherent Limitations For decades, Selective Serotonin Reuptake Inhibitors (SSRIs) have been a primary treatment for depression, based on the theory of correcting a “serotonin imbalance.” However, this model is definitively challenged by significant clinical limitations and recent research highlighting a more complex neurobiological reality.[1], [2] Delayed Onset of Therapeutic […]

Read More →